Abstract
Recombinant soluble p55 TNF receptor induces remission, is non-immunogenic and well tolerated in active Crohn's disease: Results of a randomized pilot trial
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
